Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway
- 5 February 2016
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 35 (4), 2391-2397
- https://doi.org/10.3892/or.2016.4613
Abstract
Extensive exposure to estrogen is generally acknowledged as a risk factor for endometrial cancer. Given that the accumulation of adipocytes also contributes to the increased production of estrogen, in the present study, we evaluated the expression of the fat mass and obesity-associated (FTO) gene in endometrial tumor tissues and further explored the mechanism of how estrogen facilitates FTO nuclear localization and promotes endometrial cancer cell proliferation. Immunohistochemical (IHC) staining assay was used to detect the FTO expression in endometrial tumor samples. Western blotting was performed to investigate the mechanism of estrogen-induced FTO nuclear localization. siRNA was used to knock down ERα and further explore its role in FTO nuclear localization. MTT assay was carried out to determine cell proliferation. We found that FTO was overexpressed in endometrial carcinoma tissues and served as a poor prognostic marker. Additionally, estrogen induced FTO nuclear accumulation via the mTOR signaling pathway and the nuclear localization was ERα-dependent, which contributed to enhanced proliferative activity. Therefore, the present study provides new insight into the mechanisms of estrogen-induced proliferation, implying the possibility of using FTO as a potential therapeutic target for the treatment of endometrial cancer.Keywords
This publication has 30 references indexed in Scilit:
- The inflammation and estrogen metabolism impacts of polychlorinated biphenyls on endometrial cancer cellsToxicology in Vitro, 2015
- Single nucleotide polymorphisms of the FTO gene and cancer risk: an overviewMolecular Biology Reports, 2014
- Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer riskMolecular Biology Reports, 2013
- Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathwaysCancer Letters, 2012
- The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer riskThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- The role of the fat mass and obesity associated gene (FTO) in breast cancer riskBMC Medical Genetics, 2011
- No Association between FTO or HHEX and Endometrial Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2010
- Biological Roles of Estrogen and Progesterone in Human Endometrial Carcinoma - New developments in potential endocrine therapy for endometrial cancer -Endocrine Journal, 2007
- A review of selective estrogen receptor modulators in the treatment of breast and endometrial cancerSeminars in Oncology, 2002
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983